Based upon the above observations, we hypothesized that IL-6 and TGFβ1 in the neuroblastoma microenvironment may contribute to the failure of treatment with mAb ch14.18 by suppressing anti-tumor functions of NK cells. Here, IL6 is linked to neuroblastoma.